A program to improve cancer care for the community
Morehouse Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
This study is trying to improve cancer care for African American patients by collecting health information and biological samples to help develop better treatments tailored to their needs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Morehouse School of Medicine Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Trial ID | NCT04804878 on ClinicalTrials.gov |
What this trial studies
The Morehouse Total Cancer Care program aims to enhance cancer treatment standards by creating a centralized biorepository of biological samples and associated data from thousands of African American cancer patients and those at risk. This observational study will collect blood, tissue, and other biological samples, along with survey and medical records data, to facilitate biomarker discovery and personalized medicine approaches. Participants will provide informed consent to allow researchers to study their health information and biological materials over their lifetime. The initiative focuses on translating research findings into community oncology practices.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and older who have been diagnosed with cancer or are at risk of developing cancer.
Not a fit: Patients who are under 18 years old or do not have a cancer diagnosis or risk may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could lead to improved cancer care and personalized treatment options for patients.
How similar studies have performed: Other studies have shown success in establishing biorepositories for cancer research, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years of age and older. 2. Diagnosed with cancer, or at risk for cancer. This includes anyone in the general population, but our primary focus will be on patients with a cancer diagnosis. 3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through an authorized representative. The Informed Consent and Research Authorization will be available in both English and Spanish languages Exclusion Criteria: None \-
Where this trial is running
Atlanta, Georgia
- Morehouse School of Medicine — Atlanta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: James W Lillard, PhD — Morehouse School of Medicine
- Study coordinator: LaTrisha Horne
- Email: totalcancercare@msm.edu
- Phone: 404-752-1034
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.